690 LEE ROAD,
WAYNE , PA, 19087
WAYNE , PA, 19087
Summary
The fund seeks capital appreciation in the long term by investing in companies across any size outside the United States.
The sub-adviser’s investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.
Next, the research team invests in securities of health care-related companies worldwide. More
Link
Directors
Jan 12, 2024- Paul L. Rosenberg
- James E. Davey
- Andrew A. Johnson
- Robin C. Beery
- Derrick D. Cephas
- Hilary E. Ackermann
- Christine R. Detrick
- David Sung
- John J. Gauthier
Chief Compliance Officer
- Joseph G. Melcher
Fund Manager(s)
- Ann Gallo
- Robert Deresiewicz
- Rebecca Sykes
- Wen Shi
- David Khtikian
- Fayyaz Mujtaba
Price
- 52-Week High/Low
- $46.66 - $35.62
- Turnover
- 34%
- Expense Ratio
- 1.01%
Company Name |
Holding |
| Eli Lilly & Co | 10.16 % |
| UnitedHealth Group Inc | 9.03 % |
| Danaher Corp | 3.77 % |
| Merck & Co Inc | 3.64 % |
| Boston Scientific Corp | 3.12 % |
| Thermo Fisher Scientific Inc | 3.08 % |
| Vertex Pharmaceuticals Inc | 2.67 % |
| Stryker Corp | 2.29 % |
| HCA Healthcare Inc | 2.17 % |
| Cencora Inc | 1.99 % |
| More | 1.99 % |
Advisor
Documents
Performance
YTD
3.4%
3 Year
-10.37%
5 Year
13.71%
Best
26.7%
2014
Worst
-25.32%
2008
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | 7.5% | -3.7% | -7.6% | -9.9% | -13.4% | 14.2% | 1.6% | 12.7% | -12.4% | 9.6% |
| Q2 | -2.8% | 5.8% | -9.5% | 20.1% | 21% | 1.3% | 6.8% | 8.2% | 7% | 5.2% |
| Q3 | - | -5.9% | -4.5% | -11.3% | -5.3% | -4% | 8.6% | 1.5% | 2.7% | -11.8% |
| Q4 | - | 8.9% | 9.8% | 3.9% | 10.6% | 12.8% | -15.8% | -2.4% | -4.8% | 10.9% |
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 1.4% | 3.7% | 2.1% | -3.7% | - | - | - | - | - | - | - | - |
| 2023 | -0.6% | -4.6% | 1.5% | 4.1% | -2.6% | 4.4% | -0.4% | -1.3% | -4.2% | -3.7% | 6.6% | 5.7% |
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 3% | 4% | -12% | -0% | 10% | 26% | -3% | 22% | -8% | 13% |
Alpha
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| HGHIX | 3% | 4% | -12% | -0% | 10% | 26% | -3% | 22% | -8% | 13% |
| S&P 500 | - | - | -21% | 27% | 16% | 29% | -6% | 19% | 10% | -1% |
| Alpha | 3% | 4% | 9% | -27% | -6% | -3% | 3% | 3% | -18% | 14% |